Table 1.
Characteristics | Total | Before QI interventions | After QI interventions | p-valuea |
---|---|---|---|---|
Total patients, n (%) | 1185 | 483 | 702 | 0.212 |
AKI | 986 (83.2) | 394 (81.6) | 592 (84.3) | |
ESKD | 199 (16.8) | 89 (18.4) | 110 (15.7) | |
Age (years), mean ± SD | 56.6 ± 14.2 | 55.9 ± 13.9 | 57.1 ± 14.4 | 0.147 |
Sex, male, n (%) | 712 (60.1) | 290 (60.0) | 422 (60.1) | 0.980 |
Race, n (%) | 0.254 | |||
White | 1087 (91.7) | 441 (91.3) | 646 (92.0) | |
Black | 91 (7.7) | 41 (8.5) | 50 (7.1) | |
Other | 7 (0.6) | 1 (0.2) | 6 (0.9) | |
Weight (kg), median [IQR] | 90.9 [75.0–109.9] | 90.8 [71.0–110.0] | 91.0 [77.0–109.1] | 0.229 |
Hospital LOS (days), median [IQR] | 14.6 [5.7–28.8] | 14.0 [6.0–27.9] | 15.1 [5.4–29.4] | 0.544 |
ICU LOS (days), median [IQR] | 8.9 [3.8–19.2] | 8.6 [3.8–15.5] | 9.6 [3.9–20.7] | 0.072 |
Mechanical ventilation (days), median [IQR] | 4.0 [1.0–8.0] | 3.5 [1.0–7.3] | 4.0 [1.0–8.0] | 0.278 |
Total CRRT days, median [IQR] | 3.1 [1.4–7.0] | 3.0 [1.2–6.5] | 3.3 [1.6–7.4] | 0.086 |
SOFA score at ICU admission, median [IQR] | 12.0 [9.0–14.0] | 12.0 [10.0–15.0] | 12.0 [9.0–14.0] | 0.198 |
SOFA score at CRRT initiation, median [IQR] | 14.0 [11.0–16.0] | 13.0 [11.0–15.0] | 14.0 [11.0–16.0] | 0.476 |
CCI score, median [IQR] | 4.0 [2.0–7.0] | 5.0 [3.0–7.0] | 4.0 [2.0–6.0] | 0.030 |
Discharge disposition, n (%) | 0.167 | |||
Alive | 507 (42.8) | 219 (45.3) | 288 (41.0) | |
Dead | 678 (57.2) | 264 (54.7) | 414 (59.0) |
Before QI interventions period included data from September 2016 to December 2017 (total of 16 months before and during QI interventions). After QI interventions period included data from January 2018 to June 2019 (18 months).
AKI acute kidney injury, CCI Charlson comorbidity index, CRRT continuous renal replacement therapy, ESKD end-stage kidney disease, ICU intensive care unit, LOS length of stay, QI quality improvement, SOFA sequential organ failure assessment.
ap-value of comparison for data before and after QI interventions.